AMBER SIMMONS: Open Payments
NPI 1922477884 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,072 in 66 payments from 15 companies in 2025. Trend: 2023 $937 · 2024 $1,193 · 2025 $1,072
Food & beverage: $1,072
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 16 | $227 |
| AstraZeneca Pharmaceuticals LP | 10 | $179 |
| Novo Nordisk Inc | 13 | $174 |
| Merck Sharp & Dohme LLC | 4 | $74 |
| GlaxoSmithKline, LLC. | 4 | $72 |
| Astellas Pharma US Inc | 3 | $61 |
| Phathom Pharmaceuticals, Inc. | 3 | $58 |
| Amgen Inc. | 3 | $51 |
| Inspire Medical Systems, Inc. | 2 | $41 |
| SANOFI PASTEUR INC. | 2 | $37 |
Products named: MOUNJARO, Ozempic, JARDIANCE, VERQUVO, TRELEGY ELLIPTA, FARXIGA, Veozah, VOQUEZNA.
Industry payments across AL — which companies pay providers there.
